BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32849187)

  • 1. Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis.
    Lanznaster D; Bejan-Angoulvant T; Gandía J; Blasco H; Corcia P
    Front Neurol; 2020; 11():697. PubMed ID: 32849187
    [No Abstract]   [Full Text] [Related]  

  • 2. CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis.
    Agah E; Saleh F; Sanjari Moghaddam H; Saghazadeh A; Tafakhori A; Rezaei N
    Syst Rev; 2018 Dec; 7(1):237. PubMed ID: 30572951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low 25OH Vitamin D Blood Levels Are Independently Associated With Higher Amyotrophic Lateral Sclerosis Severity Scores: Results From a Prospective Study.
    Juntas-Morales R; Pageot N; Marin G; Dupuy AM; Alphandery S; Labar L; Esselin F; Picot MC; Camu W
    Front Neurol; 2020; 11():363. PubMed ID: 32547467
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis.
    Karam C; Barrett MJ; Imperato T; MacGowan DJ; Scelsa S
    J Clin Neurosci; 2013 Nov; 20(11):1550-3. PubMed ID: 23815870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis.
    Zhu Y; Yang M; Li F; Li M; Xu Z; Yang F; Liu Y; Chen W; Zhang Y; Xu R
    Int J Biol Sci; 2018; 14(9):1041-1053. PubMed ID: 29989057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D in amyotrophic lateral sclerosis.
    Libonati L; Onesti E; Gori MC; Ceccanti M; Cambieri C; Fabbri A; Frasca V; Inghilleri M
    Funct Neurol; 2017; 32(1):35-40. PubMed ID: 28380322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2012 Dec; 12():CD005225. PubMed ID: 23235621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis.
    Lanznaster D; Bejan-Angoulvant T; Patin F; Andres CR; Vourc'h P; Corcia P; Blasco H
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):199-206. PubMed ID: 30961401
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of pulmonary rehabilitation program on amyotrophic lateral sclerosis: A meta-analysis of randomized controlled trials.
    Su CL; Tam KW; Fang TP; Chiang LL; Chen HC
    NeuroRehabilitation; 2021; 48(3):255-265. PubMed ID: 33814477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D is Not a Protective Factor in ALS.
    Blasco H; Madji Hounoum B; Dufour-Rainfray D; Patin F; Maillot F; Beltran S; Gordon PH; Andres CR; Corcia P
    CNS Neurosci Ther; 2015 Aug; 21(8):651-6. PubMed ID: 26096806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cannabinoids in Amyotrophic Lateral Sclerosis (ALS) murine models: a systematic review and meta-analysis.
    Urbi B; Owusu MA; Hughes I; Katz M; Broadley S; Sabet A
    J Neurochem; 2019 Apr; 149(2):284-297. PubMed ID: 30520038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein levels in patients with amyotrophic lateral sclerosis: A systematic review.
    Kharel S; Ojha R; Preethish-Kumar V; Bhagat R
    Brain Behav; 2022 Mar; 12(3):e2532. PubMed ID: 35201675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease.
    Guo J; Zhou M; Yang M; Zhu C; He L
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008554. PubMed ID: 21901724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and effectiveness of high-calorie therapy for treating amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Zhu Q; Xu D; Huang H; Li D; Yang D; Zhou J; Zhao Y
    J Neurol; 2023 Oct; 270(10):4729-4743. PubMed ID: 37369861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Therapeutic Exercise Slow Down Progressive Functional Decline in Patients With Amyotrophic Lateral Sclerosis? A Meta-Analysis.
    Park D; Kwak SG; Park JS; Choo YJ; Chang MC
    Front Neurol; 2020; 11():853. PubMed ID: 32903629
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and correlates of fatigue in amyotrophic lateral sclerosis: A systematic review and meta-analysis.
    Hamad AA; Amer BE; Abbas NB; Alnajjar AZ; Meshref M
    Neurol Sci; 2024 Feb; 45(2):485-493. PubMed ID: 37837507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D supplementation for prevention of mortality in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
    Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review and Meta-Analyses of Aminopeptidases as Prognostic Biomarkers in Amyotrophic Lateral Sclerosis.
    Teruel-Peña B; Gómez-Urquiza JL; Suleiman-Martos N; Prieto I; García-Cózar FJ; Ramírez-Sánchez M; Fernández-Martos C; Domínguez-Vías G
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.